Starling William N JR 4
4 · TRANSENTERIX, INC. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Starling William N JR
Director
Transactions
- Sale
Common Stock
2019-12-19$1.39/sh−3,587$4,986→ 17,983 total(indirect: See Footnote) - Sale
Common Stock
2019-12-19$1.44/sh−6,015$8,662→ 11,968 total(indirect: See Footnote)
Holdings
- 1,568
Common Stock
- 18,134(indirect: See Footnote)
Common Stock
- 131,102(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]Shares of Common Stock sold by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
- [F2]Reflects a reverse stock split of the Registrant's common stock at a ratio of one-for-thirteen with marketplace effectiveness on December 12, 2019 whereby the resulting fractional share was rounded up to the nearest whole share.
- [F3]The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.44 to $1.445 inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F4]Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C.
- [F5]Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.